v1
OP0313 COST-EFFECTIVENESS OF A JAK1/JAK2-INHIBITOR VS. A BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG IN A TREAT-TO-TARGET STRATEGY FOR RHEUMATOID ARTHRITIS
Identifier:nobleid.org/w1/20260515/5EB74EB0
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/5EB74EB0)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →